0001836461-20-000001.txt : 20201215
0001836461-20-000001.hdr.sgml : 20201215
20201215151027
ACCESSION NUMBER: 0001836461-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201215
DATE AS OF CHANGE: 20201215
EFFECTIVENESS DATE: 20201215
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Resilient Biotics, Inc.
CENTRAL INDEX KEY: 0001836461
IRS NUMBER: 814591350
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-383270
FILM NUMBER: 201389413
BUSINESS ADDRESS:
STREET 1: 2 DAVIS DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 717-350-3133
MAIL ADDRESS:
STREET 1: 2 DAVIS DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
D
1
primary_doc.xml
X0708
D
LIVE
0001836461
Resilient Biotics, Inc.
2 DAVIS DRIVE
RESEARCH TRIANGLE PARK
NC
NORTH CAROLINA
27709
717-350-3133
DELAWARE
None
None
Corporation
true
2016
Christopher
Belnap
2 Davis Drive
Durham
NC
NORTH CAROLINA
27709
Executive Officer
Director
Greg
Werner
2 Davis Drive
Durham
NC
NORTH CAROLINA
27709
Executive Officer
Director
John
Peryam
2 Davis Drive
Durham
NC
NORTH CAROLINA
27709
Director
Eric
Eason
2 Davis Drive
Durham
NC
NORTH CAROLINA
27709
Director
Biotechnology
Decline to Disclose
- 06b
false
2020-12-02
false
true
false
0
7172432
7172432
0
false
18
0
0
0
true
Proceeds will be used for working capital, which may include normal compensation to executive officers.
false
Resilient Biotics, Inc.
Christopher Belnap
Christopher Belnap
CEO
2020-12-09